Year |
Citation |
Score |
2021 |
Kong W, Dimitri A, Wang W, Jung IY, Ott CJ, Fasolino M, Wang Y, Kulikovskaya I, Gupta M, Yoder T, DeNizio JE, Everett JK, Williams EF, Xu J, Scholler J, ... Reich TJ, et al. BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia. The Journal of Clinical Investigation. 131. PMID 34396987 DOI: 10.1172/JCI145459 |
0.487 |
|
2018 |
Ruella M, Xu J, Barrett DM, Fraietta JA, Reich TJ, Ambrose DE, Klichinsky M, Shestova O, Patel PR, Kulikovskaya I, Nazimuddin F, Bhoj VG, Orlando EJ, Fry TJ, Bitter H, et al. Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. Nature Medicine. PMID 30275568 DOI: 10.1038/S41591-018-0201-9 |
0.468 |
|
2018 |
Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, Reich TJ, Cogdill AP, Morrissette JJD, DeNizio JE, Reddy S, Hwang Y, Gohil M, Kulikovskaya I, Nazimuddin F, Gupta M, et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature. PMID 29849141 DOI: 10.1038/S41586-018-0178-Z |
0.487 |
|
2016 |
Lacey SF, Xu J, Ruella M, Barrett DM, Kulikovskaya I, Ambrose DE, Patel PR, Reich T, Scholler J, Nazimuddin F, Fraietta JA, Maude SL, Gill SI, Levine BL, Nobles CL, et al. Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR Blood. 128: 281-281. DOI: 10.1182/Blood.V128.22.281.281 |
0.427 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Reich TJ, Lewis PW. A goldilocks amount of H3K27me3. Nature Chemical Biology. PMID 36973441 DOI: 10.1038/s41589-023-01295-5 |
0.297 |
|
2016 |
DeMicco A, Reich T, Arya R, Rivera-Reyes A, Fisher MR, Bassing CH. Lymphocyte Lineage-Specific and Developmental Stage Specific Mechanisms Suppress Cyclin D3 Expression in Response to DNA Double Strand Breaks. Cell Cycle (Georgetown, Tex.). 0. PMID 27327568 DOI: 10.1080/15384101.2016.1198861 |
0.231 |
|
Hide low-probability matches. |